🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Start Date
2023-11-13
Trial ID
NCT05870579
Treatments Being Tested
The purpose of this study is to increase our understanding of how much chol...
Status
Completed
Location
University of North Carolina
Start Date
2007-06
Trial ID
NCT00065546
A retrospective study of de-identified (to preserve patient privacy) patien...
Status
Completed
Location
Pfizer New York
Start Date
2023-09-29
Trial ID
NCT06086340
Treatments Being Tested
The purpose of this study is to microscopically examine breast cancer cells...
Status
Terminated
Location
Mount Sinai West
Start Date
2016-10
Trial ID
NCT02936206
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of first-line tr...
Status
Completed
Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Start Date
2018-05-24
Trial ID
NCT03462251
Postmenopausal women often face risks of vascular dysfunction and muscle de...
Status
Completed
Location
National Yang Ming Chiao Tung University
Start Date
2025-06-09
Trial ID
NCT06958965
Treatments Being Tested
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
This is a randomized trial for patients with metastatic hormone receptor (H...
Status
Completed
Location
University of Alabama at Birmingham (UAB)
Start Date
2016-03
Trial ID
NCT02632045
Treatments Being Tested
This research study is evaluating a drug called Palbociclib in combination ...
Status
Completed
Location
University of California, San Francisco
Start Date
2014-01
Trial ID
NCT02040857
Treatments Being Tested
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested